39
Participants
Start Date
September 29, 2017
Primary Completion Date
May 27, 2020
Study Completion Date
May 27, 2020
90Y-DOTA tyr3-Octreotide
90Y-DOTATOC is a radiopharmaceutical that will be used as a treatment for both children and adults with neuroendrocrine and other somatostatin receptor positive tumors.
68Ga-DOTATOC PET Positron Emission Tomography (PET) whole body scan
68Ga-DOTATOC is a radiopharmaceutical used in PET scans to identify tumors as it can adhere to Somatostatin Receptors.
Amino Acids
This is a solution of amino acids that will decrease the amount of 90Y-DOTATOC that recirculates through the body after injection, therefore decreasing the radiation dose to the kidneys.
University of Iowa Hospitals and Clinics, Iowa City
National Institutes of Health (NIH)
NIH
National Cancer Institute (NCI)
NIH
University of Iowa
OTHER